Completed NA INTERVENTIONAL 6-arm NCT01737229

Efficacy and the Safety Study of RD94 in Patients With Endodontic Care (RD94)

Open Trial, Not Randomized Study Evaluating the Efficacy and the Tolerance of RD94 in Patients Needing Endodontic Care, Medical Device Class III

Sponsor: AscoPharm is conducting the study under the responsibility of SEPTODONT

Conditions Tooth Injury

Interventions Application of Biodentine™ (RD94), dentin substitute

Updated 5 times since 2017 Last updated: Jul 23, 2013 Started: Jan 31, 2010 Primary completion: Apr 30, 2013 Completion: Apr 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Tooth Injury, this trial is completed. The trial is conducted by AscoPharm is conducting the study under the responsibility of SEPTODONT and has accumulated 5 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AscoPharm is conducting the study under the responsibility of SEPTODONT
Ascopharm Groupe Novasco

Data source: Ascopharm Groupe Novasco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France